SH3BGRL
(SH3 Domain Binding Glutamic Acid-Rich Protein Like (SH3BGRL))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-SH3BGRL antibody (Catalog #: ARP48218_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
SH3BGRL
(SH3 Domain Binding Glutamic Acid-Rich Protein Like (SH3BGRL))
Synonymes
sh3bgr Peptide, SH3BGR Peptide, 1190008F14Rik Peptide, SH3BGRL Peptide, RGD1560520 Peptide, SH3 domain binding glutamate-rich protein like L homeolog Peptide, SH3 domain binding glutamate rich protein like Peptide, SH3-binding domain glutamic acid-rich protein like Peptide, SH3 domain binding glutamate-rich protein like Peptide, SH3 domain binding glutamic acid-rich protein like Peptide, sh3bgrl.L Peptide, SH3BGRL Peptide, Sh3bgrl Peptide, sh3bgrl Peptide
Sujet
SH3BGRL belongs to the SH3BGR family. Mutations in predicted EVH1-binding domain of SH3BGRL had a modest effect on suppression of v-Rel transformation.